Therefore, the broad spectrum of cancer phenotypes potentially accompanying the germline alterations in CDKN2A suggests that it could be regarded as a candidate for tumor predisposition beyond melanoma and pancreatic cancer in clinical practice30,39. Here, CDKN2A is linked to cancer.